Commonwealth Biotechnologies gets delisting warning

Commonwealth Biotechnologies, a Chesterfield-based biotech firm that has made several international deals lately, received a delisting notice from NASDAQ for failure to meet certain filing rules. The stock is down $0.11, or 17 percent,